{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:17:28Z","timestamp":1792786648589,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R33CA12196"],"award-info":[{"award-number":["R33CA12196"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01HL076438"],"award-info":[{"award-number":["R01HL076438"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["M01RR07122"],"award-info":[{"award-number":["M01RR07122"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA012197"],"award-info":[{"award-number":["P30CA012197"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["BCTR0707769"],"award-info":[{"award-number":["BCTR0707769"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Susan G. Komen Foundation","id":[{"id":"https:\/\/ror.org\/02nadbe75","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institutes of Health, Siemens, Bracco, and Prova"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jcmg.2012.11.017","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T17:32:16Z","timestamp":1367429536000},"page":"877-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":341,"title":["Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease"],"prefix":"10.1016","volume":"6","author":[{"given":"Brandon C.","family":"Drafts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie M.","family":"Twomley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ralph","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Avis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie R.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Thohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Melin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Torti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Gregory","family":"Hundley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2012.11.017_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/COC.0b013e318142c865","article-title":"Competing causes of death for women with breast cancer and change over time from 1975 to 2003","volume":"31","author":"Du","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jcmg.2012.11.017_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djk064","article-title":"Long-term risk of cardiovascular disease in 10-year survivors of breast cancer","volume":"99","author":"Hooning","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmg.2012.11.017_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","article-title":"Myocardial infarction mortality risk after treatment for Hodgkin\u2019s disease: a collaborative British cohort study","volume":"99","author":"Swerdlow","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmg.2012.11.017_bib4","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-induced cardiomyopathy","volume":"339","author":"Singal","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2012.11.017_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurjhf\/hfq213","article-title":"Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"13","author":"Eschenhagen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2012.11.017_bib6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2337\/db08-1192","article-title":"Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the Multi-Ethnic Study of Atherosclerosis","volume":"58","author":"Rerkpattanapipat","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmg.2012.11.017_bib7","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.jacc.2006.03.072","article-title":"Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis","volume":"48","author":"Heckbert","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2012.11.017_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1532-429X-11-55","article-title":"Myocardial tissue tagging with cardiovascular magnetic resonance","volume":"11","author":"Shehata","year":"2009","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2012.11.017_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/mrm.10509","article-title":"Real-time imaging of two-dimensional cardiac strain using a harmonic phase magnetic resonance imaging (HARP-MRI) pulse sequence","volume":"50","author":"Sampath","year":"2003","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jcmg.2012.11.017_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.2009.23.8527","article-title":"Aortic stiffness increases upon receipt of anthracycline chemotherapy","volume":"28","author":"Chaosuwannakit","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2012.11.017_bib11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2012.11.017_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcrc.2009.12.001","article-title":"Troponin-I as a prognosticator of mortality in severe sepsis patients","volume":"25","author":"John","year":"2010","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jcmg.2012.11.017_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejheart.2004.03.009","article-title":"Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction","volume":"7","author":"Daugaard","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2012.11.017_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJMoa0903515","article-title":"Sensitive troponin I assay in early diagnosis of acute myocardial infarction","volume":"361","author":"Keller","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2012.11.017_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cardfail.2004.09.002","article-title":"A\u00a0conceptual model of the quality of life in relation to heart failure","volume":"11","author":"Rector","year":"2005","journal-title":"J\u00a0Cardiac Failure"},{"key":"10.1016\/j.jcmg.2012.11.017_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2001.26431","article-title":"Anthracycline-induced cardiomyopathy","volume":"28","author":"Keefe","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jcmg.2012.11.017_bib17","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk of vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2012.11.017_bib18","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","article-title":"2009 focused update: ACCF\/AHA guidelines for the diagnosis and management of heart failure in adults","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2012.11.017_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2012.11.017_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2010.194118","article-title":"Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy","volume":"96","author":"Cheung","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2012.11.017_bib21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCIMAGING.109.862334","article-title":"Prediction of all cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring","volume":"2","author":"Stanton","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2012.11.017_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/10976640009148691","article-title":"Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance","volume":"2","author":"Bellenger","year":"2000","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2012.11.017_bib23","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2010.06.044","article-title":"Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction","volume":"56","author":"Hung","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2012.11.017_bib24","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","article-title":"Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients","volume":"37","author":"Laurent","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jcmg.2012.11.017_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/hy0102.099031","article-title":"Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study","volume":"39","author":"Boutouyrie","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jcmg.2012.11.017_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2012.11.017_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/10976640600737664","article-title":"Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing\u2019s sarcoma","volume":"8","author":"Perel","year":"2006","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2012.11.017_bib28","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2012.11.017_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCHEARTFAILURE.111.964221","article-title":"Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the Minnesota Living with Heart Failure Questionnaire in the Irbesartan in Heart Failure with Perserved Systolic Function (I-PRESERVE) Trial","volume":"5","author":"Rector","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jcmg.2012.11.017_bib30","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0735-1097(00)00511-8","article-title":"Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction","volume":"35","author":"Quinones","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.jcmg.2012.11.017_bib31","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/j.amjcard.2009.10.007","article-title":"Cardiovascular disease risk factors: epidemiology and risk assessment","author":"Dahlof","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2012.11.017_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/pbc.21633","article-title":"Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity","volume":"51","author":"Germanakis","year":"2008","journal-title":"Pediatr Blood Cancer"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X13002593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X13002593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:40:05Z","timestamp":1761846005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X13002593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1936878X13002593"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2012.11.017","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2012.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}